Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.60)
# 597
Out of 4,829 analysts
139
Total ratings
51.11%
Success rate
3.53%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Outperform | $300 → $310 | $249.53 | +24.23% | 13 | May 1, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $640 → $600 | $380.64 | +57.63% | 15 | Apr 21, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $333.46 | +12.46% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.11 | +68.78% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $62.79 | +35.37% | 17 | Dec 13, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $28.58 | +29.46% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $353.70 | +13.09% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $136.68 | +22.91% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $110.91 | +30.74% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $10.43 | +283.51% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.50 | +42.86% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $10.28 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $570.22 | +13.99% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $95.30 | +52.15% | 10 | Oct 28, 2022 |
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $249.53
Upside: +24.23%
UnitedHealth Group
Apr 21, 2025
Maintains: Outperform
Price Target: $640 → $600
Current: $380.64
Upside: +57.63%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $333.46
Upside: +12.46%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.11
Upside: +68.78%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $62.79
Upside: +35.37%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $28.58
Upside: +29.46%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $353.70
Upside: +13.09%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $136.68
Upside: +22.91%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $110.91
Upside: +30.74%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $10.43
Upside: +283.51%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.50
Upside: +42.86%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $10.28
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $570.22
Upside: +13.99%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $95.30
Upside: +52.15%